METHODS AND MATERIALS FOR TREATING DIARRHEA
This document relates to methods and materials for administering bile acid sequestrants to treat conditions associated with diarrhea. For example, formulations designed for the delivery of a bile acid sequestrant (e.g., colesevelam) to treat diarrhea are provided.
1 . A method for treating a diarrhea condition, said method comprising administering to a mammal having said diarrhea condition a composition comprising a bile acid sequestrant.
2 . The method of claim 1 , wherein said mammal is a human.
3 . The method of claim 1 , wherein said diarrhea condition is bile acid malabsorption induced diarrhea.
4 . The method of claim 1 , wherein said bile acid sequestrant is colesevelam.
5 . The method of claim 1 , wherein said composition is administered to said mammal under conditions wherein the amount of said bile acid sequestrant in said composition is between about 1 gram and about 5 grams.
6 . The method of claim 5 , wherein said composition is administered to said mammal between once every other day to four times a day.
7 . The method of claim 1 , wherein said method comprises assessing said mammal before said administering step to determine if said mammal comprises a serum level of 7αC4 greater than about 25 ng/mL of serum, wherein the presence of said serum level indicates that said mammal is to be administered said bile acid sequestrant.
8 . The method of claim 7 , wherein said serum level of 7αC4 is a fasting serum level of 7αC4.
9 . The method of claim 1 , wherein said method comprises assessing said mammal before said administering step to determine if said mammal comprises a serum level of 7αC4 greater than about 30 ng/mL of serum, wherein the presence of said serum level indicates that said mammal is to be administered said bile acid sequestrant.
10 . A method for treating a diarrhea condition, said method comprising (a) identifying a mammal having said diarrhea condition and a serum level of 7αC4 greater than about 25 ng/mL of serum, and (b) administering a composition comprising a bile acid sequestrant to said identified mammal under conditions wherein the severity of said diarrhea condition is reduced.
11 . The method of claim 10 , wherein said serum level of 7αC4 is a fasting serum level of 7αC4.
12 . A method for treating a diarrhea condition, said method comprising (a) identifying a mammal having (i) said diarrhea condition, (ii) a serum level of 7αC4 greater than about 20 ng/mL of serum, and (iii) a potential bile acid malabsorption condition based on a fecal bile acid excretion test or 75 SeHCAT retention test, and (b) administering a composition comprising a bile acid sequestrant to said identified mammal under conditions wherein the severity of said diarrhea condition is reduced.
13 . The method of claim 12 , wherein said fecal bile acid excretion test is a 48 hour fecal bile acid excretion test.
14 . The method of claim 12 , wherein said 75 SeHCAT retention test is a 75 SeHCAT retention test at 7 days.